Literature DB >> 31601702

Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain Injury.

April Alcantara1, Gholam R Berenji1,2, Carole S Scherling3, Beata Durcanova1, Daniel Diaz-Aguilar1, Daniel H S Silverman4.   

Abstract

Neuronuclear imaging has been used for several decades in the study of primary neurodegenerative conditions, such as dementia and parkinsonian syndromes, both for research and for clinical purposes. There has been a relative paucity of applications of neuronuclear imaging to evaluate nonneurodegenerative conditions that can also have long-term effects on cognition and function. This article summarizes clinical and imaging aspects of 3 such conditions that have garnered considerable attention in recent years: cancer- and chemotherapy-related cognitive impairment, posttraumatic stress disorder, and traumatic brain injury. Further, we describe current research using neuroimaging tools aimed to better understand the relationships between the clinical presentations and brain structure and function in these conditions.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  PTSD; cancer; chemotherapy; chronic traumatic brain injury; neuroimaging; posttraumatic

Year:  2019        PMID: 31601702     DOI: 10.2967/jnumed.119.237578

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  1 in total

1.  Characterization of cognitive function in survivors of diffuse gliomas using resting-state functional MRI (rs-fMRI).

Authors:  Chencai Wang; Kathleen Van Dyk; Nicholas Cho; Catalina Raymond; Justin Choi; Noriko Salamon; Whitney B Pope; Albert Lai; Timothy F Cloughesy; Phioanh L Nghiemphu; Benjamin M Ellingson
Journal:  Brain Imaging Behav       Date:  2021-08-05       Impact factor: 3.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.